In 2023, the FDA classified BPC-157 as a Category 2 bulk drug substance, restricting its use by compounding pharmacies
It is not a single compound and not a pharmaceutical product
Earths Future 10 , e2021EF002567 (2022)
In an open uncontrolled trial in 20 men with idiopathic infertility and a low testosterone-to-estrogen ratio, three months of treatment with letrozole resulted in improved sperm motility and morphology, reduced sperm DNA fragmentation, increased testosterone-to-estrogen ratio, and four spontaneous pregnancies
The package arrived securely sealed
More recent research has explored AOD9604 for other potential applications beyond obesity, including osteoarthritis treatment based on observations of cartilage regeneration properties in preclinical models, though clinical validation of these additional indications is limited